Nabriva Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Market Capitalization	0	58	325	365	1,034	978	2,194	127	202	-	-
Market Cap Growth	-	-82.20%	-10.85%	-64.72%	5.76%	-55.43%	1630.01%	-37.19%	-	-	-
Enterprise Value	-2	51	285	331	982	899	2,108	43	90	31	16
PE Ratio	-0.88	-1.01	-6.58	-5.25	-12.50	-8.52	-29.51	-2.31	-4.30	-	-
PS Ratio	0.00	1.57	11.26	72.58	109.08	101.28	412.51	19.57	53.60	-	-
PB Ratio	-2.96	17.59	6.10	11.01	25.06	14.25	26.74	1.64	1.86	-	-
P/FCF Ratio	-3.71	-1.57	-5.46	-5.11	-14.37	-13.41	-31.11	-2.59	-9.15	-	-
P/OCF Ratio	-3.74	-1.58	-5.46	-5.12	-14.39	-13.45	-31.64	-2.62	-9.24	-	-
EV/Sales Ratio	1.58	1.37	9.88	65.84	103.59	93.15	396.22	6.63	24.02	12.86	0.57
EV/EBITDA Ratio	-0.87	-0.92	-6.02	-4.95	-12.45	-7.88	-29.06	-0.78	-3.60	-2.79	0.73
EV/EBIT Ratio	-0.87	-0.92	-5.94	-4.89	-12.39	-7.85	-28.89	-0.77	-3.57	-2.75	0.73
EV/FCF Ratio	-3.58	-1.37	-4.79	-4.63	-13.65	-12.33	-29.89	-0.88	-4.10	-2.68	-3.93
Debt / Equity Ratio	-0.03	1.59	0.15	0.23	0.84	0.35	0.00	-	-	-0.99	-1.09
Debt / EBITDA Ratio	-0.01	-0.10	-0.17	-0.12	-0.44	-0.21	0.00	-	-	-2.97	0.91
Debt / FCF Ratio	-0.04	-0.14	-0.13	-0.11	-0.48	-0.33	0.00	-	-	-2.85	-4.88
Quick Ratio	0.26	0.70	2.71	2.46	5.39	5.98	6.99	5.66	13.01	0.13	0.33
Current Ratio	0.38	1.13	3.59	3.09	5.48	6.11	7.08	5.71	13.03	0.12	0.31
Asset Turnover	1.03	0.74	0.34	0.09	0.10	0.09	0.06	0.07	0.06	0.47	-
Interest Coverage	-112.44	-78.68	-53.34	-41.05	-23.39	-861.64	-1696.70	-739.83	-1.15	-3.85	2.46
Return on Equity (ROE)	-2673.20%	-211.50%	-82.10%	-207.80%	-179.90%	-139.90%	-100.00%	-65.40%	-124.40%	55.00%	-
Return on Assets (ROA)	-191.60%	-114.00%	-57.40%	-125.60%	-89.00%	-111.90%	-82.20%	-55.80%	-76.90%	-278.40%	-
Return on Capital (ROIC)	342.39%	-651.75%	-79.06%	-161.83%	-104.90%	-123.85%	-89.63%	-71.25%	-25.53%	2778.18%	958.39%
Earnings Yield	-17044582.04%	-98.75%	-15.20%	-19.04%	-8.00%	-11.74%	-3.39%	-43.28%	-23.26%	-	-
FCF Yield	-4032198.14%	-63.76%	-18.32%	-19.58%	-6.96%	-7.46%	-3.21%	-38.58%	-10.93%	-	-
Buyback Yield / Dilution	-27.72%	-54.67%	-237.48%	-73.12%	-46.07%	-70.28%	-38.89%	-102.93%	-3159.12%	-	-
Total Shareholder Return	-27.72%	-54.67%	-237.48%	-73.12%	-46.07%	-70.28%	-38.89%	-102.93%	-3159.12%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).